Activated protein C analog with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact
about
Cytoprotective-selective activated protein C therapy for ischaemic strokePhase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteersActivated protein C: biased for translation.Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury.An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents.Protease-Activated Receptor-1 Supports Locomotor Recovery by Biased Agonist Activated Protein C after Contusive Spinal Cord Injury.Cytoprotective protein C pathways and implications for stroke and neurological disordersInhibition of Nogo-66 receptor 1 enhances recovery of cognitive function after traumatic brain injury in mice.Activated protein C promotes neuroprotection: mechanisms and translation to the clinic.An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway.Activated protein C analog promotes neurogenesis and improves neurological outcome after focal ischemic stroke in mice via protease activated receptor 1Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats.2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C.3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice.Controversial treatment of a victim of severe head injury complicated by septic shock and acute respiratory distress syndrome.Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice.Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C.
P2860
Q27009122-536612AB-7BDD-4262-9833-31957EEC280AQ33693490-C5B9177A-B14E-4E37-BAC8-E16275F83610Q35583397-9E6C2435-E4E3-41EC-9F24-07478241151CQ35682342-F3DCBB93-4BA9-480E-9125-CC818565DB9CQ36195195-F44061E3-CAB3-42A9-95EF-0D560CD3DEF0Q36259819-DAF094BC-F69B-4733-B9E0-A79062C23572Q36379329-66EB8E7B-3F68-47F5-8875-F69F7BC31DE6Q36629711-1C6D4C7F-CC18-4DAF-ABE7-87E1FA6D49B4Q36997361-3378563C-0114-4394-8EB3-123A03CDF914Q37000469-E9C1AB48-A47E-4BFC-B742-5353A27A69E4Q37085780-54489223-11F0-4767-946B-D4156F12E62DQ37552150-2BF82143-B7CF-4693-8555-F50245643AB9Q38985138-B5DB15F7-BD38-4EDD-9B6D-B43E64D7939AQ40826783-6FF30241-0178-4009-8EF7-491AC46BD347Q40835493-E431ED76-8D55-4D20-87D9-5B7BC088091EQ42929508-A868917F-7C4C-4F00-87AC-93902B815049Q46037752-36F93867-B051-4271-9D93-E13678582EB0
P2860
Activated protein C analog with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activated protein C analog wit ...... ing controlled cortical impact
@ast
Activated protein C analog wit ...... ing controlled cortical impact
@en
type
label
Activated protein C analog wit ...... ing controlled cortical impact
@ast
Activated protein C analog wit ...... ing controlled cortical impact
@en
prefLabel
Activated protein C analog wit ...... ing controlled cortical impact
@ast
Activated protein C analog wit ...... ing controlled cortical impact
@en
P2093
P2860
P1433
P1476
Activated protein C analog wit ...... ing controlled cortical impact
@en
P2093
Andrew H Marky
Anthony L Petraglia
Berislav V Zlokovic
Corey T Walker
Nienwen Chow
P2860
P304
P356
10.1016/J.BRAINRES.2010.05.075
P407
P577
2010-06-01T00:00:00Z